M. Hoffmann, S. Deshmukh, T. Werner
FULL PAPER
ppm. 13C NMR (75 MHz, CDCl3): δ = 51.51 (CH3), 118.17 (CH),
128.93 (2 CH), 129.01 (2 CH), 132.65 (C), 135.94 (C), 143.11 (CH),
166.84 (C=O) ppm. C10H9ClO3 (212.63): calcd. C 61.08, H 4.61,
Cl 18.03; found C 60.99, H 4.33, Cl 17.90.
Methyl (E)-3-(3-Bromophenyl)propenoate (3s):[43] According to the
GP, 3-bromobenzaldehyde (1s; 305 mg, 1.65 mmol), methyl bromo-
acetate (2a; 303 mg, 1.98 mmol), Bu3P=O (54 mg, 0.25 mmol,
15 mol-%), PhSiH3 (268 mg, 2.48 mmol), and 1,2-epoxybutane
(238 mg, 3.30 mmol) in dioxane (0.8 mL) were converted for 2 h.
Purification (SiO2, CH/EtOAc, 10:1) gave a mixture of 3s (224 mg,
reddish oil. H NMR (300 MHz, CDCl3): δ = 3.80 (s, 3 H, CH3),
6.25 (d, J = 15.7 Hz, 1 H, CH), 7.04–7.08 (m, 1 H, ArH), 7.25–
7.27 (m, 1 H, ArH), 7.37–7.39 (m, 1 H, ArH), 7.80 (d, J = 15.7 Hz,
1 H, CH) ppm. 13C NMR (75 MHz, CDCl3): δ = 51.49 (CH3),
116.34 (CH), 127.92 (CH), 128.32 (CH), 130.80 (CH), 137.11 (CH),
139.31 (C), 167.06 (C=O) ppm.
1
Methyl (E)-3-(2-Benzofuranyl)propenoate (3x):[48] According to the
GP, benzofuran-2-carbaldehyde (2x; 161 mg, 1.10 mmol), methyl
bromoacetate (2a; 202 mg, 1.32 mmol), Bu3P=O (36 mg,
0.17 mmol), PhSiH3 (179 mg, 1.65 mmol), and 1,2-epoxybutane
(159 mg, 2.20 mmol) in dioxane (0.6 mL) were converted for 2 h.
Purification (SiO2, CH/EtOAc, 20:1) gave 3x (130 mg, 58%, E/Z =
53%, E/Z
= 99:1) and methyl 3-(3-bromophenyl)propanoate
(25 mg, 10%) as a colorless solid. Data for 3s: 1H NMR (300 MHz,
CDCl3): δ = 3.81 (s, 3 H, CH3), 6.42 (d, J = 16.0 Hz, 1 H, CH),
7.22–7.26 (m, 1 H, ArH), 7.41–7.44 (m, 1 H, ArH), 7.48–7.50 (m,
1 H, ArH), 7.59 (d, J = 16.0 Hz, 1 H, CH), 7.63–7.67 (m, 1 H,
ArH) ppm. 13C NMR (75 MHz, CDCl3): δ = 51.63 (CH3), 119.09
(CH), 122.83 (C), 126.48 (CH), 130.19 (CH), 130.55 (CH), 132.85
(CH), 136.26 (C), 142.89 (CH), 166.69 (C=O) ppm.
1
91:9) as a yellowish solid. H NMR (300 MHz, CDCl3): δ = 3.83
(s, 3 H, CH3), 6.59 (d, J = 15.6 Hz, 1 H, CH), 6.90–6.95 (m, 1 H,
CH), 7.22–7.28 (m, 1 H, CH), 7.33–7.40 (m, 1 H, CH), 7.45–7.52
(m, 1 H, CH), 7.54–7.61 (m, 3 H, CH) ppm. 13C NMR (75 MHz,
CDCl3): δ = 51.68 (CH3), 111.10 (CH), 111.28 (CH), 118.31 (CH),
121.63 (CH), 123.20 (CH), 126.34 (CH), 128.20 (C), 131.33 (CH),
152.13 (C), 155.41 (C), 166.97 (C=O) ppm.
Methyl (E)-3-(4-Bromophenyl)propenoate (3t):[43,44] According to
the GP, 4-bromobenzaldehyde (1t; 305 mg, 1.65 mmol), methyl
bromoacetate (2a; 303 mg, 1.98 mmol), Bu3P=O (54 mg,
0.25 mmol, 15 mol-%), PhSiH3 (268 mg, 2.48 mmol), and 1,2-ep-
oxybutane (238 mg, 3.30 mmol) in dioxane (0.8 mL) were con-
verted for 2 h. Purification (SiO2, CH/EtOAc, 20:1) gave 3t
(244 mg, 61%, E/Z = 98:2) as a colorless solid. 1H NMR
(300 MHz, CDCl3): δ = 3.81 (s, 3 H, CH3), 6.43 (d, J = 16.0 Hz, 1
H, CH), 7.37–7.41 (m, 2 H, ArH), 7.51–7.54 (m, 2 H, ArH), 7.63
(d, J = 16.0 Hz, 1 H, CH) ppm. 13C NMR (75 MHz, CDCl3): δ =
51.66 (CH3), 118.34 (CH), 124.41 (C), 129.31 (2 CH), 131.99 (2
CH), 133.13 (C), 143.31 (CH), 166.96 (C=O) ppm.
Methyl (E)-5,9-Dimethyldeca-2,8-dienoate (5a):[17a,17b] According to
the GP, 3,7-dimethyloct-6-enal (4a; 159 mg, 1.03 mmol), methyl
bromoacetate (2a; 189 mg, 1.24 mmol), Bu3P=O (34 mg,
0.16 mmol, 15 mol-%), PhSiH3 (167 mg, 1.55 mmol) and 1,2-ep-
oxybutane (149 mg, 2.06 mmol) in dioxane (0.5 mL) were con-
verted for 1 h. Purification (SiO2, CH/EtOAc, 20:1) gave 5a
1
(124 mg, 57%, E/Z = 93:7) as a colorless oil. H NMR (300 MHz,
CDCl3): δ = 0.91 (d, J = 6.7 Hz, 3 H, CH3), 1.12–1.42 (m, 3 H,
CH2), 1.59–1.63 (m, 3 H, CH3), 1.66–1.71 (m, 3 H, CH3), 1.91–
2.10 (m, 3 H, CH2), 2.17–2.27 (m, 1 H, CH), 3.73 (s, 3 H, CH3),
5.05–5.12 (m, 1 H), 5.82 (dt, J = 15.6, J = 1.5 Hz, 1 H, CH), 6.90–
7.01 (m, 1 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 17.50 (CH),
19.34 (CH3), 25.36 (CH2), 25.57 (CH3), 31.95 (CH3), 36.54 (CH2),
39.52 (CH2), 51.20 (CH3), 121.86 (CH), 124.27 (CH), 131.28 (C),
148.37 (CH), 166.86 (C=O) ppm.
Methyl (E)-3-(2-Trifluoromethylphenyl)propenoate (3u):[45] Accord-
ing to the GP, 2-trifluoromethylbenzaldehyde (1u; 352 mg,
1.89 mmol), methyl bromoacetate (2a; 348 mg, 2.27 mmol),
Bu3P=O (62 mg, 0.28 mmol, 15 mol-%), PhSiH3 (306 mg,
2.83 mmol) and 1,2-epoxybutane (272 mg, 3.77 mmol) in dioxane
(0.5 mL) were converted for 2 h. Purification (SiO2, CH/EtOAc,
20:1) gave 3u (197 mg, 54%, E/Z = 73:27) as a yellowish oil. 1H
NMR (300 MHz, CDCl3): δ = 3.84 (s, 3 H, CH3), 6.42 (d, J =
15.8 Hz, 1 H, CH), 7.40–7.74 (m, 4 H), 8.04–8.11 (m, 1 H, ArH)
ppm. 13C NMR (75 MHz, CDCl3): δ = 51.87 (CH3), 122.11 (CH),
Methyl (E)-Trideca-2,12-dienoate (5b):[49] According to the GP, 10-
undecenal (4b; 282 mg, 1.67 mmol), methyl bromoacetate (2a;
307 mg, 2.01 mmol), Bu3P=O (55 mg, 0.25 mmol), PhSiH3
(272 mg, 2.51 mmol), and 1,2-epoxybutane (241 mg, 3.35 mmol) in
dioxane (0.8 mL) were converted for 1 h. Purification (SiO2, CH/
EtOAc, 20:1) gave 5b (312 mg, 83%, E/Z = 93:7) as a colorless oil.
1H NMR (300 MHz, CDCl3): δ = 1.25–1.50 (m, 12 H, CH2), 2.00–
2.09 (m, 2 H, CH2), 2.16–2.24 (m, 2 H, CH2), 3.73 (s, 3 H, CH3),
4.90–5.04 (m, 2 H, CH), 5.75–5.89 (m, 2 H, CH), 6.98 (dt, J =
15.6, J = 7.0 Hz, 1 H, CH) ppm. 13C NMR (75 MHz, CDCl3): δ
= 27.91 (CH2), 28.80 (CH2), 28.99 (CH2), 29.01 (CH2), 29.24
(CH2), 29.26 (CH2), 32.11 (CH2), 33.69 (CH2), 51.22 (CH3), 114.05
(CH), 120.73 (CH), 139.00 (CH), 149.64 (CH), 167.03 (C=O) ppm.
1
3
123.86 (q, JC,F = 273.0 Hz, CF3), 126.11 (q, JC,F = 5.6 Hz, CH),
2
127.84 (CH), 128.80 (q, JC,F = 30.4 Hz, C), 129.56 (CH), 132.06
3
(CH), 133.28 (C), 140.25 (d, JC,F = 2.0 Hz, CH), 166.48 (C=O)
ppm. 19F NMR (282 MHz, CDCl3): δ = –58.56 ppm.
Methyl (E)-3-(2-Furyl)propenoate (3v):[40,46] According to the GP,
2-furylcarbaldehyde (2v; 83 mg, 0.86 mmol), methyl bromoacetate
(2a; 158 mg, 1.03 mmol), Bu3P=O (28 mg, 0.13 mmol, 15 mol-%),
PhSiH3 (140 mg, 1.29 mmol), and 1,2-epoxybutane (124 mg,
1.72 mmol) in dioxane (0.4 mL) were converted for 2 h. Purification
(SiO2, CH/EtOAc, 20:1) gave 3v (47 mg, 36%, E/Z = 90:10) as an
Methyl (E)-6-(5,5-Dimethyl-1,3-dioxanyl)hex-2-enoate (5c): Accord-
ing to the GP, 4-(5,5-dimethyl-1,3-dioxanyl)butyraldehyde (4c;
397 mg, 2.13 mmol), methyl bromoacetate (2a; 392 mg,
2.56 mmol), Bu3P=O (70 mg, 0.32 mmol, 15 mol-%), PhSiH3
(346 mg, 3.20 mmol), and 1,2-epoxybutane (308 mg, 4.26 mmol) in
dioxane (1.1 mL) were converted for 2 h. Purification (SiO2, CH/
EtOAc, 20:1) gave 5c (310 mg, 60%, E/Z = 93:7) as a colorless oil.
1H NMR (300 MHz, CDCl3): δ = 0.71 (s, 3 H, CH3), 1.18 (s, 3 H,
CH3), 1.53–1.72 (m, 4 H, CH2), 2.18–2.26 (m, 2 H, CH2), 3.38–
1
orange oil. H NMR (300 MHz, CDCl3): δ = 3.79 (s, 3 H, CH3),
6.32 (d, J = 15.7 Hz, 1 H, CH), 6.46–6.48 (m, 1 H, ArH), 6.60–
6.63 (m, 1 H, ArH), 7.44 (d, J = 15.7 Hz, 1 H, CH), 7.48–7.49 (m,
1 H, ArH) ppm. 13C NMR (75 MHz, CDCl3): δ = 51.55 (CH3),
112.19 (CH), 114.74 (CH), 115.33 (CH), 131.11 (CH), 144.67 (CH),
150.77 (C), 167.39 (C=O) ppm.
Methyl (E)-3-(2-Thienyl)propenoate (3w):[47] According to the GP, 3.44 (m, 2 H, OCH2), 3.56–3.61 (m, 2 H, OCH2), 3.71 (s, 3 H,
2-thienylcarbaldehyde (2w; 140 mg, 1.25 mmol), methyl bromoacet-
ate (2a; 229 mg, 1.50 mmol), Bu3P=O (41 mg, 0.19 mmol, 15 mol-
%), PhSiH3 (203 mg, 1.88 mmol), and 1,2-epoxybutane (180 mg,
2.50 mmol) in dioxane (0.6 mL) were converted for 2 h. Purification
(SiO2, CH/EtOAc, 10:1) gave 3w (123 mg, 58%, E/Z = 88:12) as a
CH3), 4.40–4.45 (m, 1 H, CH), 5.82 (dt, J = 15.6, J = 1.6 Hz, 1 H,
CH), 6.96 (dt, J = 15.6, J = 6.9 Hz, 1 H, CH) ppm. 13C NMR
(75 MHz, CDCl3): δ = 21.62 (CH3), 22.09 (CH2), 22.76 (CH3),
29.91 (C), 31.78 (CH2), 33.97 (CH2), 51.11 (CH3), 76.95 (2 CH2),
101.45 (CH), 120.96 (CH), 148.89 (CH), 166.77 (C=O) ppm. MS
4540
www.eurjoc.org
© 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2015, 4532–4543